Branko Huisa is a Neurology physician affiliated with Precision Research Institute. OpenAlex indexes 46 publications with 1,242 citations (h-index 17).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
44045 Margarita Rd Ste 106
Temecula, CA 925922729
Telephone
951-462-4624Provider last certified this registry record 30 Nov 2021.
Industry payments
51 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- ABBVIE INC.Program year202548 payments
- Neurocrine BioSciences, Inc.Program year202516 payments
- Abbott LaboratoriesProgram year20253 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Nervous system
72.3%Amyloid Beta-directed Antibody64.8%Lecanemab-irmb100%Part B, office-administered≥17 patientsSSRI1%Sertraline Hcl56%Escitalopram Oxalate13%Trazodone Hcl13%Citalopram Hbr8%Fluoxetine Hcl7%Paroxetine Hcl2%Part D<11 patients+ 22 more classes in this area
Musculoskeletal
26.5%Neuromuscular Blocker26.4%Onabotulinumtoxina100%Part B, office-administered≥32 patientsgamma-Aminobutyric Acid-ergic Agonist0.1%Baclofen100%Part D≥29 patientsCardiovascular
0.9%Beta blocker0.3%Propranolol Hcl Er55%Propranolol Hcl29%Metoprolol Succinate9%Atenolol8%Part D<11 patientsAngiotensin receptor blocker (ARB)0.3%Losartan Potassium58%Losartan-Hydrochlorothiazide42%Part D≥30 patients+ 5 more classes in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Promotores program to increase Hispanic/Latino(a) participation in Alzheimer's disease research
Alzheimer s & Dementia Translational Research & Clinical Interventions
2026 - Overcoming Barriers to Latino Participation in Alzheimer's Disease Research
The International Journal of Aging and Human Development
2024 - T2 Protect AD: Achieving a rapid recruitment timeline in a multisite clinical trial for individuals with mild to moderate Alzheimer's disease
Alzheimer s & Dementia Translational Research & Clinical Interventions
2022 - Using Biomarkers to Predict Memantine Effects in Alzheimer’s Disease: A Proposal and Proof-Of-Concept Demonstration
Journal of Alzheimer s Disease
2021
Similar KOLs
Other experts from the same institution or the same specialty.
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”